EUVIMEDEUVIMED entdecken
Crossref

The use of therapeutic second-generation antipsychotics level monitoring in the individualization of schizophrenia pharmacotherapy

Anna Králová, Petr Potměšil, Miloslav Kopeček

Klinická farmakologie a farmacie · 29.04.2025 · 39 (1) · 57-61

DOI: 10.36290/far.2025.020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Klinická farmakologie a farmacie, erschienen am 29.04.2025. Verfasst von Anna Králová und 2 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Králová, A., Potměšil, P., & Kopeček, M. (2025). The use of therapeutic second-generation antipsychotics level monitoring in the individualization of schizophrenia pharmacotherapy. Klinická farmakologie a farmacie, 39(1), 57-61. https://doi.org/10.36290/far.2025.020

Vancouver

Králová A, Potměšil P, Kopeček M. The use of therapeutic second-generation antipsychotics level monitoring in the individualization of schizophrenia pharmacotherapy. Klinická farmakologie a farmacie. 2025;39(1):57-61. doi:10.36290/far.2025.020

BibTeX
@article{Krlov2025,
  author = {Králová, Anna and Potměšil, Petr and Kopeček, Miloslav},
  title = {The use of therapeutic second-generation antipsychotics level monitoring in the individualization of schizophrenia pharmacotherapy},
  journal = {Klinická farmakologie a farmacie},
  year = {2025},
  volume = {39},
  number = {1},
  pages = {57--61},
  doi = {10.36290/far.2025.020}
}
Kostenlos starten →